Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1/2 1

Status

Completed 4Terminated 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 3Gastrointestinal 1

Conditions

Stomatitis 3Head and Neck Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Oral Ulcer 1Esophagitis 1Carcinoma, Squamous Cell 1

Interventions

Paclitaxel 337pembrolizumab 332Carboplatin 329Cisplatin 276Gemcitabine 264Docetaxel 251Bevacizumab 239Nivolumab 230Pemetrexed 210Rituximab 183Dexamethasone 183Cyclophosphamide 169Capecitabine 169Trastuzumab 149Fluorouracil 147Ipilimumab 121atezolizumab 118Prednisone 117Erlotinib Hydrochloride 116Oxaliplatin 109Cetuximab 104Sunitinib 101Leucovorin 97Doxorubicin 97Lenalidomide 93Irinotecan 89130-nm albumin-bound paclitaxel 84durvalumab 77Bortezomib 77Azacitidine 73

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Has results × avasopasem manganese × Clear all
NCT03340974 2023-12-15

Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer

Galera Therapeutics, Inc.

Phase 1/2 Completed
42 enrolled 13 charts
Gastrointestinal

Pancreatic Neoplasms

NCT03689712 2023-10-24

ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients

Galera Therapeutics, Inc.

Phase 3 Completed
455 enrolled 11 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Stomatitis, Oral Ulcer

NCT04225026 2023-03-23

Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer

Galera Therapeutics, Inc.

Phase 2 Terminated
39 enrolled 12 charts

Esophagitis

NCT04529850 2022-08-16

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

Galera Therapeutics, Inc.

Phase 2 Completed
38 enrolled 10 charts
Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT02508389 2021-09-20

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Galera Therapeutics, Inc.

Phase 2 Completed
223 enrolled 17 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡